The Medicines Company ( MDCO ) recently announced that it has completed its acquisition of Incline Therapeutics, Inc., for an upfront fee of $185 million. In addition, The
The Medicines Company ( MDCO ) recently announced that it has completed its acquisition of Incline Therapeutics, Inc., for an upfront fee of $185 million. In addition, The